Concepedia

Adverse events with sodium-glucose co-transporter-2 inhibitors: A global analysis of international spontaneous reporting systems

Emanuel Raschi, Matteo Parisotto, Emanuele Forcesi, M. La Plaça, Giulio Marchesini, Fabrizio De Ponti, Elisabetta Poluzzi

Nutrition Metabolism and Cardiovascular Diseases · 2017 · 47 citations · 19 references

DOIFull text

Open access

Concepts

References

19

Stevens–Johnson Syndrome and Toxic Epidermal Necrolysis: Assessment of Medication Risks with Emphasis on Recently Marketed Drugs. The EuroSCAR-Study

Maja Mockenhaupt, Cécile Viboud, Ariane Dunant et al. · Journal of Investigative Dermatology · 2007 · 998 citations · Full text

, , +14

Oral Pharmacologic Treatment of Type 2 Diabetes Mellitus: A Clinical Practice Guideline From the American College of Physicians

Amir Qaseem, Linda L. Humphrey, Donna E. Sweet et al. · Annals of Internal Medicine · 2012 · 401 citations

, , +17

SGLT2 inhibitors and diabetic ketoacidosis: data from the FDA Adverse Event Reporting System

Gian Paolo Fadini, Benedetta Maria Bonora, Angelo Avogaro · Diabetologia · 2017 · 241 citations · Full text

, , +16

Assessing the Association of Pioglitazone Use and Bladder Cancer Through Drug Adverse Event Reporting

Carlo Piccinni, Domenico Motola, Giulio Marchesini et al. · Diabetes Care · 2011 · 238 citations · Full text

, , +14

Oral Pharmacologic Treatment of Type 2 Diabetes Mellitus: A Clinical Practice Guideline Update From the American College of Physicians

Amir Qaseem, Michael J. Barry, Linda L. Humphrey et al. · Annals of Internal Medicine · 2017 · 207 citations

, , +17